NEW
YORK, July 4, 2024 /PRNewswire/ -- The
global sleep apnea implants market size is estimated to grow
by USD 401.75 thousand from
2024-2028, according to Technavio. The market is estimated to grow
at a CAGR of 15.2% during the forecast period. Increasing
prevalence of sleep apnea and respiratory disorders is driving
market growth, with a trend towards rising awareness about sleep
apnea. However, regulatory challenges in global sleep apnea
implants market poses a challenge. Key market players include
Advanced Brain Monitoring Inc., Asahi Kasei Corp., Avery Biomedical
Devices Inc., Cleveland Medical Devices Inc., Contec Medical
Systems Co. Ltd., DeVilbiss Healthcare GmbH, Fisher and Paykel
Healthcare Corp. Ltd., Inspire Medical Systems Inc., Koninklijke
Philips N.V., Linguaflex Inc., LivaNova PLC, Medtronic Plc, Nihon
Kohden Corp., Nox Medical, Nyxoah SA, ResMed Inc., Siesta Medical
Inc., SomnoMed Ltd., Somnowell Ltd., and Vyaire Medical Inc..
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Sleep Apnea Implants
Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
15.2%
|
Market growth
2024-2028
|
USD 401.75
th
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
12.86
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
45%
|
Key
countries
|
US, Germany, France,
China, and Japan
|
Key companies
profiled
|
Advanced Brain
Monitoring Inc., Asahi Kasei Corp., Avery Biomedical Devices Inc.,
Cleveland Medical Devices Inc., Contec Medical Systems Co. Ltd.,
DeVilbiss Healthcare GmbH, Fisher and Paykel Healthcare Corp. Ltd.,
Inspire Medical Systems Inc., Koninklijke Philips N.V., Linguaflex
Inc., LivaNova PLC, Medtronic Plc, Nihon Kohden Corp., Nox Medical,
Nyxoah SA, ResMed Inc., Siesta Medical Inc., SomnoMed Ltd.,
Somnowell Ltd., and Vyaire Medical Inc.
|
Market Driver
Sleep apnea implants are gaining significance in the healthcare
industry due to the increasing awareness about the importance of
good quality sleep for overall health and productivity. Obstructive
Sleep Apnea (OSA) is a common disorder that causes interruptions in
breathing during sleep, leading to reduced oxygen levels and
increased blood pressure. If left untreated, severe sleep apnea can
increase the risk of heart problems. To address this issue, various
organizations, key vendors, and government bodies are conducting
campaigns to promote awareness about sleep apnea and sleep apnea
implants. Key players in the market, including Koninklijke Philips,
ResMed, Fisher & Paykel Healthcare, are engaging in promotional
activities to increase awareness among both patients and healthcare
professionals. For instance, Philips launched a stand-up comedy
clip in March 2021 to educate people
about the importance of sleep and sleep disorders like sleep apnea.
Similarly, ResMed partnered with Verily to develop software
solutions for sleep apnea and other respiratory disorders.
Non-profit organizations, such as the American Sleep Association,
National Sleep Foundation, the CDC, and the National Institutes of
Health (NIH), are also conducting awareness and educational
campaigns on sleep apnea. These campaigns aim to expand and promote
awareness of sleep health and the prevention of sleep apnea. In the
UK, organizations like the Scottish Association for Sleep Apnoea
and the Sleep Apnoea Trust Association work to increase awareness
about sleep apnea. The collaborative efforts of these organizations
are expected to increase awareness about sleep apnea-related
disorders, leading to an increase in the adoption of sleep apnea
implants. This, in turn, will drive the growth of the sleep apnea
implants market during the forecast period.
The Sleep Apnea Implants market is witnessing significant growth
due to the increasing clinical trials for new devices like palatal
implants, bone screw systems, and phrenic nerve stimulators. These
implants offer effective solutions for obstructive sleep apnea
(OSA) therapy, addressing symptoms such as snoring, sleep breathing
interruptions, and daytime sleepiness. Cardiovascular conditions
like atherosclerosis, hypertension, stroke, diabetes, and
depression are linked to OSA, creating a high demand for these
implants. Technological advancements, such as midface advancement
and hypoglossal neurostimulators, improve treatment outcomes.
Symptoms like airway irritation and disturbed sleep can lead to
severe health-related complications, including fatal accidents and
sleep deprivation disorders. The adult American population
suffering from chronic sleep apnea and other sleep-related
disorders, such as insomnia, jet lag, narcolepsy, and sleepwalking,
is substantial. Obesity and a high body mass index are significant
factors contributing to OSA. Therefore, the development of these
implants is crucial for addressing the underlying causes of sleep
apnea, including throat muscle activity and upper respiratory tract
obstruction. Clinical studies and ongoing research continue to
drive innovation in this field. Inspire Therapy, a leading player
in the market, is revolutionizing OSA treatment with its innovative
approach to addressing the root cause of the condition. The future
of sleep apnea implants lies in continued technological
advancements and clinical studies to improve patient outcomes and
quality of life.
Research report provides comprehensive data on
impact of trend. For more details- Download a Sample
Report
Market Challenges
- The global sleep apnea implants market is subject to stringent
regulations, with manufacturers required to adhere to guidelines
and standards set by regulatory bodies like the US FDA and EMA.
These regulations cover various aspects, including product design,
manufacturing, labeling, and marketing. Obtaining regulatory
approval for new sleep apnea implants is a significant challenge,
with a time-consuming and costly process involving extensive data
on safety and efficacy. Frequently changing regulations add to the
complexity, and international regulations and standards further
complicate market entry for new players. Manufacturers must stay
updated on these regulations to avoid non-compliance issues and
remain competitive in the industry. These regulatory challenges
pose a barrier to market growth for the global sleep apnea implants
market.
- The sleep deprivation disorders market, including sleep apnea,
presents significant challenges for the healthcare ecosystem.
Chronic sleep apnea disorders like obstructive sleep apnea can lead
to fatal accidents, health-related complications, and disturbed
sleep. The adult American population suffering from sleep
disorders, such as insomnia, jet lag, narcolepsy, sleepwalking, and
sleep apnea, is on the rise. Sleep Apnea Implants, like Hypoglossal
neurostimulation devices from Signifier Medical Technologies, offer
effective solutions. However, high costs and stringent government
regulations pose challenges for the medical device industry. Sleep
awareness programs, sleep hygiene, technological aid through sleep
trackers, movement monitoring wearables, and sleep centers play a
crucial role in diagnosis. Sleep disorder treatments, including
surgery and medical practices, aim to improve natural breathing
mechanisms and oxygen flow. Peri-operative complications and
inspiring medical systems are areas of ongoing research. Sleep
Apnea Week highlights the importance of addressing these challenges
and promoting awareness. Additionally, conditions like peripheral
artery disease and limb ischemia can further complicate sleep apnea
management.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This sleep apnea implants market report extensively covers
market segmentation by
- Indication
- 1.1 Central sleep apnea
- 1.2 Obstructive sleep apnea
- End-user
- 2.1 Ambulatory surgical centers
- 2.2 Hospitals
- 2.3 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Central sleep apnea- Central sleep apnea, a
condition characterized by the brain's inability to send proper
signals to breathing muscles during sleep, can lead to serious
health complications, including heart disease, diabetes, glaucoma,
cancer, cognitive and behavioral disorders. Rising awareness and
diagnosis of this condition are driving the demand for effective
treatment options. Sleep apnea implants, which are the most common
treatment for central sleep apnea, are experiencing market growth
due to the increasing prevalence of the condition, new product
launches, and better insurance coverage. Advanced implant
technology, such as devices designed specifically for central sleep
apnea, are expanding treatment options for those who cannot
tolerate or find traditional therapies, like continuous positive
airway pressure machines, adequate. Market vendors are employing
strategies like product portfolio expansion and collaborations to
expand their geographic reach, further fueling market growth during
the forecast period.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data
(2017-2021) - Download a Sample Report
Research Analysis
Sleep deprivation disorders, including sleep apnea, can lead to
fatal accidents and health-related complications due to disturbed
sleep and sleepiness. Sleep apnea disorder, a common sleep-related
disorder, disrupts the natural breathing mechanism during sleep,
leading to oxygen flow interruptions. Symptoms include snoring,
sleepiness, insomnia, and sleep-related breathing disorders. High
costs and stringent government regulations make Sleep Apnea
Implants an attractive solution for some patients. These devices,
such as those offered by Inspire Medical System, help restore
normal breathing by stimulating the airway muscles to keep the
airway open during sleep. However, peri-operative complications and
airway irritation are potential risks. Jet lag and other factors
can also exacerbate sleep apnea symptoms. The healthcare ecosystem
continues to explore innovative solutions to address the growing
prevalence of sleep apnea and improve patient outcomes.
Market Research Overview
Sleep deprivation disorders, including sleep apnea, can lead to
fatal accidents, health-related complications, and disturbed sleep.
Sleep Apnea Implants, such as Hypoglossal neurostimulation devices,
are gaining popularity as effective sleep apnea treatments. These
devices stimulate the hypoglossal nerve to maintain the airway
during sleep, improving sleep quality and reducing sleepiness.
Sleep disorders, including insomnia, jet lag, narcolepsy,
sleepwalking, and sleep apnea, affect a significant portion of the
adult American population. Chronic sleep apnea disorders can lead
to cardiovascular conditions like atherosclerosis, hypertension,
stroke, diabetes, and depression. The medical device industry is
investing in sleep apnea devices, including sleep trackers,
wearables, and movement monitoring technology. Sleep awareness
programs, sleep hygiene, and technological aid are also crucial in
managing sleep disorders. During Sleep Awareness Week, various
healthcare ecosystem players, including hospitals, care centers,
and sleep centers, focus on raising awareness and providing
diagnosis and treatment options. Sleep apnea disorder, such as
Obstructive Sleep Apnea (OSA), disrupts natural breathing
mechanisms by obstructing oxygen flow. High costs and stringent
government regulations pose challenges to the market's growth.
Peri-operative complications and the need for surgery are also
concerns. However, technological advancements, such as Midface
advancement, OSA therapy, and Hypoglossal neurostimulator, offer
promising solutions. Symptoms of sleep apnea include snoring,
airway irritation, and sleep breathing interruptions. The severity
of these symptoms can vary, and clinical studies are ongoing to
develop new treatments, including Palatal implants, bone screw
systems, and Phrenic nerve stimulators. Additionally, factors like
body mass index, obesity, and upper respiratory tract issues can
contribute to sleep apnea. Muscle activity and clinical trials are
also areas of focus in the development of sleep apnea implants.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Indication
-
- Central Sleep Apnea
- Obstructive Sleep Apnea
- End-user
-
- Ambulatory Surgical Centers
- Hospitals
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sleep-apnea-implants-market-size-is-set-to-grow-by-usd-401-75-thousand-from-2024-2028--increasing-prevalence-of-sleep-apnea-and-respiratory-disorders-boost-the-market-technavio-302188959.html
SOURCE Technavio